Trial: 202003159

A Study of Front Line Ibrutinib for Newly Diagnosed Chronic Graft-versus-Host Disease

Phase

II

Principal Investigator

Pusic, Iskra

Disease Site

Bone Marrow Transplant; Other Hematopoietic

Learn more about this study at: clinicaltrials.gov